Skip to main
DBD
DBD logo

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is experiencing anticipated growth in its Retail segment, particularly in Europe, with expected sequential and year-over-year sales increases in the third and fourth quarters. The company is on track to deliver significantly positive free cash flow (FCF), projected to nearly double to approximately $205 million by 2025. Additionally, Diebold Nixdorf's balance sheet and liquidity are reported to be in optimal condition, indicating a strong potential for further FCF conversion improvement.

Bears say

Diebold Nixdorf Inc faces several significant challenges that contribute to a negative outlook for its stock. Key risks include the company's potential inability to manage tariff-related costs effectively and disruptions in product shipments due to ongoing supply chain challenges, which could adversely affect operational efficiency. Additionally, lower than anticipated upgrade and replacement activity in the Banking segment, coupled with the volatility of currency exchange rates and a concerning liquidity situation characterized by low average daily trading volume, raises further concerns about the company's financial stability and growth prospects.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.